ArticleAnnals of hematology2025

Olverembatinib for 8p11 myeloproliferative syndrome with a positive BCR-FGFR1 fusion gene: a case report.

Man Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.